Cargando…

Systematic Profiling of Immune Risk Model to Predict Survival and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma

BACKGROUND AND PURPOSE: Head and neck squamous carcinoma (HNSCC), characterized by immunosuppression, is a group of highly heterogeneous cancers. Although immunotherapy exerts a promising influence on HNSCC, the response rate remains low and varies in assorted primary sites. Immunological mechanisms...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xingyu, Chen, Jiarui, Lu, Wei, Zeng, Zihang, Li, Jiali, Jiang, Xueping, Gao, Yanping, Gong, Yan, Wu, Qiuji, Xie, Conghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596453/ https://www.ncbi.nlm.nih.gov/pubmed/33193693 http://dx.doi.org/10.3389/fgene.2020.576566

Ejemplares similares

Integrated analysis reveals common DNA methylation patterns of alcohol-associated cancers: A pan-cancer analysis
por: Liu, Xingyu, et al.
Publicado: (2023)

Systematic Analyses of a Chemokine Family-Based Risk Model Predicting Clinical Outcome and Immunotherapy Response in Lung Adenocarcinoma
por: Chen, Jiarui, et al.
Publicado: (2021)

Immune and stromal scoring system associated with tumor microenvironment and prognosis: a gene-based multi-cancer analysis
por: Zeng, Zihang, et al.
Publicado: (2021)

Immune Infiltration Characteristics and a Gene Prognostic Signature Associated With the Immune Infiltration in Head and Neck Squamous Cell Carcinoma
por: Zhu, Chunmei, et al.
Publicado: (2022)

Immunomodulation of NK Cells by Ionizing Radiation
por: Chen, Jiarui, et al.
Publicado: (2020)

Identification of Two m6A Readers YTHDF1 and IGF2BP2 as Immune Biomarkers in Head and Neck Squamous Cell Carcinoma
por: Li, Shaojie, et al.
Publicado: (2022)

Violations of proportional hazard assumption in Cox regression model of transcriptomic data in TCGA pan-cancer cohorts
por: Zeng, Zihang, et al.
Publicado: (2022)

An integrative analysis of DNA methylation and gene expression to predict lung adenocarcinoma prognosis
por: Xu, Liexi, et al.
Publicado: (2022)

Identification and Validation of an Immune-Related RNA Signature to Predict Survival of Patients With Head and Neck Squamous Cell Carcinoma
por: Wu, Shuo, et al.
Publicado: (2019)

Pathologic evolution-related Gene Analysis based on both single-cell and bulk transcriptomics in Colorectal Cancer
por: Li, Jiali, et al.
Publicado: (2020)

SETD2 regulates gene transcription patterns and is associated with radiosensitivity in lung adenocarcinoma
por: Zeng, Zihang, et al.
Publicado: (2022)

Impact of treatment delay due to the pandemic of COVID-19 on the efficacy of immunotherapy in head and neck cancer patients
por: Chen, Gaili, et al.
Publicado: (2020)

A novel immune signature predicts immunotherapy responsiveness and reveals the landscape of the tumor immune microenvironment in head and neck squamous cell carcinoma
por: Wang, Qiwei, et al.
Publicado: (2022)

Stromal microenvironment promoted infiltration in esophageal adenocarcinoma and squamous cell carcinoma: a multi-cohort gene-based analysis
por: Li, Jiali, et al.
Publicado: (2020)

Nine-gene signature and nomogram for predicting survival in patients with head and neck squamous cell carcinoma
por: Yang, Fan, et al.
Publicado: (2022)

A Glycosyltransferase-Related Signature for Predicting Overall Survival in Head and Neck Squamous Cell Carcinoma
por: Wu, Huili, et al.
Publicado: (2022)

Additional Postoperative Radiotherapy Prolonged the Survival of Patients with I-IIA Small Cell Lung Cancer: Analysis of the SEER Database
por: Li, Jiali, et al.
Publicado: (2022)

Poor prognosis, hypomethylation, and immune infiltrates are associated with downregulation of INMT in head and neck squamous cell carcinoma
por: Cui, Kun, et al.
Publicado: (2022)

Identification of a Cancer Stem Cells Signature of Head and Neck Squamous Cell Carcinoma
por: Wu, Zeng-Hong, et al.
Publicado: (2022)

A Novel Immune-Related Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Zhang, Yi, et al.
Publicado: (2021)

LncRNA PCAT1 activates SOX2 and suppresses radioimmune responses via regulating cGAS/STING signalling in non‐small cell lung cancer
por: Gao, Yanping, et al.
Publicado: (2022)

Survival association of XRCC1 for patients with head and neck squamous cell carcinoma: A systematic review and meta-analysis
por: Yang, Fan, et al.
Publicado: (2023)

Combination of Tumor Mutational Burden and Specific Gene Mutations Stratifies Outcome to Immunotherapy Across Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma
por: Peng, Ying-Peng, et al.
Publicado: (2021)

An original cuproptosis-related genes signature effectively influences the prognosis and immune status of head and neck squamous cell carcinoma
por: Zheng, Xiwang, et al.
Publicado: (2023)

Network-Based Predictors of Progression in Head and Neck Squamous Cell Carcinoma
por: Sanati, Nasim, et al.
Publicado: (2018)

Epigenetic Regulations of Perineural Invasion in Head and Neck Squamous Cell Carcinoma
por: Hurník, Pavel, et al.
Publicado: (2022)

SETD2 mediates immunotherapy and radiotherapy efficacy via regulating DNA damage responses and genomic stability in lung adenocarcinoma
por: Zeng, Zihang, et al.
Publicado: (2022)

PLAU Promotes Cell Proliferation and Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma
por: Chen, Guangjin, et al.
Publicado: (2021)

Systemic Analysis on the Features of Immune Microenvironment Related to Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Su, Kaixin, et al.
Publicado: (2022)

Cuproptosis-Related lncRNAs are Biomarkers of Prognosis and Immune Microenvironment in Head and Neck Squamous Cell Carcinoma
por: Yang, Liuqing, et al.
Publicado: (2022)

TYK2 correlates with immune infiltration: A prognostic marker for head and neck squamous cell carcinoma
por: He, Yaodong, et al.
Publicado: (2022)

Identifying 8-mRNAsi Based Signature for Predicting Survival in Patients With Head and Neck Squamous Cell Carcinoma via Machine Learning
por: Tian, Yuxi, et al.
Publicado: (2020)

Discovery and Verification of an Immune-Related Gene Pairs Signature for Predicting Prognosis in Head and Neck Squamous Cell Carcinoma
por: He, Jiqiang, et al.
Publicado: (2021)

Long-Noncoding RNA MANCR is Associated With Head and Neck Squamous Cell Carcinoma Malignant Development and Immune Infiltration
por: Tang, Jianfei, et al.
Publicado: (2022)

Effects of immune inflammation in head and neck squamous cell carcinoma: Tumor microenvironment, drug resistance, and clinical outcomes
por: Zhu, Li, et al.
Publicado: (2022)

Immunotherapy for head and neck squamous cell carcinoma
por: Fuereder, Thorsten
Publicado: (2016)

Immunotherapy for Head and Neck Squamous Cell Carcinoma
por: Moskovitz, Jessica, et al.
Publicado: (2018)

Immunotherapy in Head and Neck Squamous Cell Cancer
por: Denaro, Nerina, et al.
Publicado: (2018)

Prediction of Radiosensitivity in Head and Neck Squamous Cell Carcinoma Based on Multiple Omics Data
por: Liu, Jie, et al.
Publicado: (2020)

Integrative Analysis of TP53INP2 in Head and Neck Squamous Cell Carcinoma
por: Cao, Ruoyan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k20041lf3thflq13hqaaidrhmj